The DOI matches its OpenAlex record.
Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992
Abstract
OBJECTIVES: To examine trends in acquired immunodeficiency syndrome (AIDS) risk behavior and human immunodeficiency virus (HIV) seroprevalence among injecting drug users (IDUs) in New York City from 1984 through 1992. DESIGN AND SETTING: Comparisons were made between two surveys of IDUs at the same hospital-based New York City drug abuse detoxification program: 141 IDUs in 1984 and 974 IDUs in 1990 through 1992. National Death Registry, New York City Health Department, and drug treatment program records were also used. PARTICIPANTS: Persons attending detoxification program randomly selected for participation. Eligibility was based on injection within previous 2 months; 99% acceptance rates were obtained. Participants in the 1984 and 1990 through 1992 surveys were 66% and 79% men, 21% and 19% white, 33% and 34% African American, and 45% and 46% Latin American, respectively. INTERVENTIONS: Community-based AIDS prevention programs, including underground syringe exchanges. MAIN OUTCOME MEASURES: Acquired immunodeficiency syndrome risk behaviors; HIV serostatus; CD4+ cell counts; death rates among 1984 subjects; and injection and intranasal routes of drug administration. RESULTS: The HIV seroprevalence remained stable at slightly more than 50%. Mean CD4+ cell counts declined from 0.716 x 10(9)/L (716/microL) to 0.575 x 10(9)/L (P < .009). Annual death rate among 1984 subjects was 3%, with a significantly higher rate among HIV-seropositive subjects (relative risk, 2.57; 95% exact binomial confidence interval, 1.12 to 6.61). Large-scale declines were observed in AIDS risk behaviors, eg, use of potentially contaminated syringes declined from 51% to 7% of injections (P < .001). Recent additional risk reduction was associated with use of the underground syringe exchanges. Intranasal heroin use was the primary route of drug administration for 46% of heroin admissions to New York City drug treatment programs. CONCLUSIONS: The HIV seroprevalence has remained stable among this population of New York City IDUs for almost a decade. Continuation of current trends should lead to further reduction in HIV transmission, although reversal of the trend to intranasal use could lead to substantially increased transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Janssen, R. S. (1998) · JAMA · doi:10.1001/jama.280.1.42 · Cited by 687
Tuberculosis in New York City — Turning the Tide
Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 640
The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.
Holmberg, S. D. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.642 · Cited by 539
HIV incidence among injecting drug users in New York City syringe-exchange programmes
Jarlais, D. C. D., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., Jose, B., & Friedman, S. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02536-6 · Cited by 406
Self-citationSociometric risk networks and risk for HIV infection.
Friedman, S. R., Neaigus, A., Jose, B., Curtis, R., Goldstein, M., Ildefonso, G., Rothenberg, R. B., & Des Jarlais, D. C. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.8.1289 · Cited by 333
Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks
Hahn, J. A., Page‐Shafer, K., Lum, P. J., Bourgois, P., Stein, E., Evans, J. L., Busch, M. P., Tobler, L. H., Phelps, B., & Moss, A. R. (2002) · The Journal of Infectious Diseases · doi:10.1086/345554 · Cited by 326
Gibson, D. R., Flynn, N. M., & Perales, D. (2001) · AIDS · doi:10.1097/00002030-200107270-00002 · Cited by 324
Wodak, A., & Cooney, A. (2006) · Substance Use & Misuse · doi:10.1080/10826080600669579 · Cited by 311
MacArthur, G. J., van Velzen, E., Palmateer, N., Kimber, J., Pharris, A., Hope, V., Taylor, A., Roy, K., Aspinall, E., Goldberg, D., et al. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.07.001 · Cited by 284
Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Hagan, H., Beatrice, S., Smith, L., Wethers, J., Milliken, J., Mildvan, D., et al. (2005) · AIDS · doi:10.1097/01.aids.0000192066.86410.8c · Cited by 163
Treating Opioid Addiction With Buprenorphine-Naloxone in Community-Based Primary Care Settings
Mintzer, I. L., Eisenberg, M., Terra, M., MacVane, C., Himmelstein, D. U., & Woolhandler, S. (2007) · The Annals of Family Medicine · doi:10.1370/afm.665 · Cited by 117
Metadata
- Authors
- Jarlais, D. C. D.
- Venue
- JAMA
- Publisher
- American Medical Association
- Published
- 1994-01-12
- Volume
- 271
- Issue
- 2
- Pages
- 121-127
- ISSN
- 0002-9955 (ISSN-L)
- OpenAlex
- W4233973010
- Cited by
- 192
- References
- 0
- FWCI
- 15.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.